Calea
Calea (now Royal Drugs) is a Canadian specialty pharmacy operator with four locations in Ontario, Alberta, and British Columbia offering specialty medications, infusion compounding, retail prescriptions, and total parenteral nutrition to patients with complex medical needs, now owned by Capital Health Partners.
- Company typePrivate
- Founded1984
- HeadquartersMississauga, Canada
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Calea does
Calea (Canada) was a Canadian specialty pharmacy operator founded in 1984, running four physical pharmacy locations in Mississauga and Hamilton, Ontario; Calgary, Alberta; and Burnaby, British Columbia. Its core services spanned four integrated lines: Specialty Pharmacy (customized medication programs for complex conditions), Infusion Compounding (home or clinic-based IV therapy), Retail Pharmacy (standard prescription fulfillment), and Total Parenteral Nutrition (TPN) for patients unable to receive enteral nutrition. The underlying technology stack described is pharmaceutical compounding and specialty pharmacy operations — there is no proprietary software, AI/ML, or platform IP disclosed, and no patents or trademarks are on file in the source data.
The business model is transaction-based pharmacy services revenue: prescriptions and infusions are dispensed to individual patients and billed through a mix of healthcare insurance, Canadian public drug plans (provincial formularies), and direct patient payments for uncovered medications. The go-to-market motion is enterprise field sales in the sense of healthcare provider referral networks and direct patient engagement through pharmacy counters, not a software-style enterprise sales motion. No disclosed enterprise customers, ARR, or revenue figures are available; customer segments are vertical use-cases (specialty, infusion, retail, TPN) rather than named accounts.
In August 2025, Calea was acquired by Capital Health Partners Inc — the parent of Ontario Medical Supply and Royal Drugs — and effective November 14, 2025 the four pharmacy locations were rebranded under the Royal Drugs name, unifying pharmacy services under a single brand alongside sister company Ontario Medical Supply. CEO Yves Portelance leads the combined entity. The company employs 251–500 people. A notice of a data security event is currently displayed on the company website, indicating an active compliance matter.
Calea firmographics
Firmographics- Name
- Calea
- Legal name
- Calea (Canada)
- Website
- https://calea.ca
- Company type
- Private
- Founded year
- 1984
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Calea (now Royal Drugs) is a Canadian specialty pharmacy operator with four locations in Ontario, Alberta, and British Columbia offering specialty medications, infusion compounding, retail prescriptions, and total parenteral nutrition to patients with complex medical needs, now owned by Capital Health Partners.
- Ownership category
- akta.pro rank
Calea industry classification
Industry- Product category
- Specialty Pharmacy Services
- NAICS
- Pharmacies and Drug Retailers (456110)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)
Keywords
Where Calea is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Offices4 records
Markets served
Calea business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
Revenue model
- Pharmacy Services Revenue: Revenue generated from dispensing specialty medications, infusion therapy compounding, retail prescriptions, and total parenteral nutrition services. Services are billed through healthcare insurance, public drug plans, and direct patient payments for uncovered medications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Specialty Pharmacy Services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Calea product offering
Product offeringCore offering
Calea (now operating under the Royal Drugs brand as of November 14, 2025) is a Canadian specialty pharmacy that dispenses customized specialty medications, compounds and administers infusion therapies in home or clinic settings, fills retail prescriptions, and prepares total parenteral nutrition (TPN) formulations. Services are delivered through four pharmacy locations in Ontario, Alberta, and British Columbia and billed through public drug plans, private insurance, and direct patient payment.
Product overview
Royal Drugs (formerly Calea) operates as a unified pharmacy platform offering four integrated core services: Specialty Pharmacy for customized medication programs, Infusion Compounding for home or clinic-based therapy, Retail Pharmacy for standard prescription services, and Total Parenteral Nutrition (TPN) for patients with advanced nutritional needs. The four pharmacy locations were consolidated under the Royal Drugs brand following the August 2025 acquisition by Capital Health Partners.
Differentiator
Problem solved
Functional benefit
Products and services
- Specialty Pharmacy Customized specialty medication programs designed to streamline healthcare practice workflows and support patients with complex medication needs, including chronic and rare disease therapies.
- Infusion Compounding Sterile compounding and administration of intravenous or injectable infusion therapies delivered safely and conveniently at the patient's home or in a clinic setting.
- Retail Pharmacy Fast and friendly prescription dispensing and pharmacy services at local pharmacy counters for standard medication needs of the general public.
- Total Parenteral Nutrition (TPN) Custom-compounded intravenous nutrition formulations for patients with advanced nutritional needs who cannot receive nutrition orally or enterally.
Companies that use Calea
Customer profileSegments4 records
Ideal customer profiles4 records
Calea technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Calea partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ontario Medical SupplyminorOntario Medical Supply is a sister company under Capital Health Partners Inc, operating alongside Royal Drugs. Both companies are subsidiaries of Capital Health Partners Inc.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
Calea competitors and assessment
Company assessmentBroad incumbents
- Accredo (Express Scripts / Evernorth): US-based specialty pharmacy owned by Evernorth/Cigna. Comparable specialty pharmacy and infusion services model at much larger US scale; serves as an upstream strategic comparable for Royal Drugs' growth pathway.
- CVS Specialty (CVS Health): Specialty pharmacy arm of CVS Health offering specialty medications, infusion, and care management nationally in the US. Comparable multi-modality specialty pharmacy business model, though at materially larger scale.
- McKesson Canada: Major pharmaceutical distributor in Canada and parent of Rexall; broader portfolio spans wholesale distribution, retail pharmacy, and specialty services — overlapping with Royal Drugs' dispensing and distribution-adjacent activities.
Direct peers
- Pharmasave: Canadian independent pharmacy network with prescription services and select specialty capabilities across the country. Comparable community-pharmacy operating model.
- Innomar Strategies (Cencora): Canada's largest specialty pharmacy and patient support provider, owned by Cencora (formerly AmerisourceBergen). Closely matches Royal Drugs' specialty pharmacy + infusion + patient services offering, but at materially greater scale.
- Bayshore HealthCare: Canadian home and community healthcare services provider offering specialty pharmacy, infusion therapy, and compounding services. Closely comparable to Royal Drugs on home infusion and specialty pharmacy model in Canada.
- Shoppers Drug Mart (Loblaw Companies): Canada's largest retail pharmacy chain, part of Loblaw, with growing specialty pharmacy capabilities. Comparable pharmacy footprint and dispensing model across Canada.
- London Drugs: Western Canadian retail pharmacy chain with prescription dispensing across BC, Alberta, Saskatchewan, and Manitoba. Geographic overlap in Calgary and Burnaby markets.
- Rexall Pharmacy: Canadian retail pharmacy chain owned by McKesson, with pharmacy dispensing and specialty medication services across multiple provinces.
- BioScript Solutions: Canadian specialty pharmacy network providing specialty medications, infusion services, and patient support programs. Direct comparable in specialty pharmacy + patient support across Canada.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Calea social profiles
Digital presenceCalea financial estimates
Financial estimateRevenue estimate
Valuation estimate
Calea leadership team
Management profileNumber of profiles
Profiles1 record
Calea funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Calea M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Calea
What does Calea do?
Calea (now operating under the Royal Drugs brand as of November 14, 2025) is a Canadian specialty pharmacy that dispenses customized specialty medications, compounds and administers infusion therapies in home or clinic settings, fills retail prescriptions, and prepares total parenteral nutrition (TPN) formulations. Services are delivered through four pharmacy locations in Ontario, Alberta, and British Columbia and billed through public drug plans, private insurance, and direct patient payment.
Is Calea a public or private company?
Calea is a private company. It is classified as corporate owned and is currently acquired.
When was Calea founded?
Calea was founded in 1984. It employs 251 to 500 people.
Where is Calea based?
Calea is headquartered in Mississauga, Canada, in the North America region.
How does Calea make money?
One revenue line is on record: pharmacy Services Revenue.
Who are Calea's main competitors?
Broad incumbents on record are Accredo (Express Scripts / Evernorth), CVS Specialty (CVS Health) and McKesson Canada. Direct peers are Pharmasave, Innomar Strategies (Cencora), Bayshore HealthCare, Shoppers Drug Mart (Loblaw Companies), London Drugs, Rexall Pharmacy and BioScript Solutions.
Does Calea have an API?
No public API is recorded for Calea.
What industry is Calea in?
Calea's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLAFALAJ, Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose). Its NAICS code is 456110 and its SIC code is 5912.